Table 1. Clinical Findings and... | American Society of Hematology

Table 1.

Clinical Findings and Laboratory Values of the 14 Patients With AL Amyloidosis Studied

Patients	Age (yr)	Main Organ Involved^-150	Monoclonal Component	BMPC %	BMPC k/λ Ratio^-151	BMPC LI%
QUA	59	Heart	BJκ	7	49.0	0.2
TAU	49	Kidney, liver	BJκ	10	5.41	ND
IAC	55	Liver	BJκ	4	61.5	0.2
ORR	65	Heart	BJκ	10	7.3	0.0
DIB	70	Kidney	BJλ	7	0.28	0.1
PAP	53	GI	BJλ	10	0.2	ND
SEM	46	Muscle, GI	BJλ	5	0.02	0.2
FER	51	Muscle, GI	BJλ	3	0.11	0.0
GHE	78	Heart	BJλ	10	0.02	0.1
FIL	57	Heart	BJλ	4	0.07	0.0
CAR	62	Skin, nerves	IgGκ + BJκ	10	40.67	0.0
SET	56	Lung	IgGλ	3	0.67	0.4
MAR	73	Heart	IgAλ	7	0.13	ND
DEP	48	Skin, heart	IgAλ + BJλ	10	0.23	0.2

Patients	Age (yr)	Main Organ Involved^-150	Monoclonal Component	BMPC %	BMPC k/λ Ratio^-151	BMPC LI%
QUA	59	Heart	BJκ	7	49.0	0.2
TAU	49	Kidney, liver	BJκ	10	5.41	ND
IAC	55	Liver	BJκ	4	61.5	0.2
ORR	65	Heart	BJκ	10	7.3	0.0
DIB	70	Kidney	BJλ	7	0.28	0.1
PAP	53	GI	BJλ	10	0.2	ND
SEM	46	Muscle, GI	BJλ	5	0.02	0.2
FER	51	Muscle, GI	BJλ	3	0.11	0.0
GHE	78	Heart	BJλ	10	0.02	0.1
FIL	57	Heart	BJλ	4	0.07	0.0
CAR	62	Skin, nerves	IgGκ + BJκ	10	40.67	0.0
SET	56	Lung	IgGλ	3	0.67	0.4
MAR	73	Heart	IgAλ	7	0.13	ND
DEP	48	Skin, heart	IgAλ + BJλ	10	0.23	0.2

Abbreviations: GI, gastrointestinal tract; BMPC, bone marrow PC; LI%, labeling index; ND, not determined.

Main organ involved at diagnosis.

Normal values are ≥1.1, ≤2.6.7